Search

Displaying results 7401 - 7410 of 7452 in total
  1. Drug

    IRX-5183

    go.drugbank.com/drugs/DB05653
    Investigational

  2. Drug

    FK-960

    go.drugbank.com/drugs/DB06465
    Experimental

  3. Drug

    Suramin

    go.drugbank.com/drugs/DB04786
    Investigational

    A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluati...

  4. Drug

    OSI-461

    go.drugbank.com/drugs/DB05415
    Investigational

    OSI-461 is a second-generation molecule belonging to a new class of drugs termed selective apoptotic anti-neoplastic drugs (SAANDs).

  5. Drug

    Fosdevirine

    go.drugbank.com/drugs/DB06166
    Investigational

  6. Drug

    Inosine 5'-sulfate

    go.drugbank.com/drugs/DB05973
    Experimental

  7. Drug

    Rubitecan

    go.drugbank.com/drugs/DB06159
    Investigational

  8. Drug

    Plevitrexed

    go.drugbank.com/drugs/DB06163
    Investigational

  9. Drug

    Perifosine

    go.drugbank.com/drugs/DB06641
    Investigational

    Perifosine is a novel alkylphospholipid with antiproliferative properties attributed to protein kinase B inhibition.

  10. Drug

    PN0621

    go.drugbank.com/drugs/DB05218
    Experimental

    PN0621 is an anti-TNF, domain antibody (dAb) based therapeutic. It targets tumour necrosis factor (TNF) to treat auto-immune inflammatory diseases such as rheumatoid arthritis. It is being developed by Peptech.